Immunochina Pharmaceuticals

Beijing, China · Founded 2015 · Privately Held (backing)

Developer of gene cell medicine technology intended for malignant tumor treatment. Immunochina Pharmaceuticals is based in Beijing, China and was founded in 2015. Its last reported valuation was $215 million in Sep 2020. It has raised $45 million.

Last reported valuation
$215.3M
Oct 2026
Priced at
—
Total raised
$45.0M
Last round
—

Who backs Immunochina Pharmaceuticals?

21 investors
InvestorType
Cowin CapitalVenture capital
Legend CapitalVenture capital
SJ Jiacheng Investment ManagementFund of funds
GF QianheVenture capital
ZGC Science CityOther
China Development Bank CapitalOther
Capital Science and Technology Development GroupOther
Thiel CapitalFamily office
China Life Private EquityOther
China Resources Capital ManagementOther
+ 11 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Immunochina Pharmaceuticals investors

21 investors are on record for Immunochina Pharmaceuticals, including Cowin Capital, Legend Capital, SJ Jiacheng Investment Management and GF Qianhe. By type, the record holds 3 venture capital firms and 2 funds of funds.

Free account
More of Immunochina Pharmaceuticals with a free account
  • ·The complete investor list: 21 names
  • ·Watch Immunochina Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like Immunochina Pharmaceuticals. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View